Research suggests that CBD may alleviate social anxiety, but the effects depend on the dose and individual responses.
THC appears to help treat PTSD symptoms, although it increases anxiety in some people, which requires caution.
Regular use of marijuana, especially with high THC content, may increase the risk of depression and psychosis in predisposed individuals, a topic of controversy.

Marijuana, with its components THC and CBD, can impact mental health, offering potential benefits but also carrying risks. In 2025, new research sheds light on its role in treating anxiety, depression, and PTSD, but also points to the need for caution.

Mental health benefits

CBD and social anxiety: 2024 studies, like meta-analysis in Psychiatry Research (Therapeutic potential of cannabidiol (CBD) in anxiety disorders), show that CBD significantly reduces anxiety, especially in social situations, with a Hedges' effect g = -0.92. This indicates high effectiveness, especially in social anxiety, where users report less stress during public speaking.

THC and CBD in PTSD therapy: Studies like those from The Lancet (2024), suggest that low doses of THC (5–10 mg) with CBD (10–20 mg) may alleviate PTSD symptoms, such as nightmares, in war veterans (The Lancet). However, the effects vary – in some people, anxiety increases, which requires an individual approach.

Risks of marijuana use

Psychosis and depression: 2025 meta-analysis in JAMA Psychiatry (JAMA Psychiatry) indicates that heavy marijuana use increases the risk of depression by 17% in young adults, especially with high THC (>20%). Research from the University of Bristol (2024) shows that young people using stronger marijuana are twice as likely to experience psychosis (2024: Cannabis – psychotic episodes).

Tips for safe use

Consultation with a doctor: Especially important for people with a history of mental illness.
Low doses: Start with 5-10 mg of CBD or 2-5 mg of THC, adjusting gradually.
Product selection: Prefer products with high CBD and low THC to minimize risk.
Breaks: Take regular breaks (2-4 weeks) every few months to prevent tolerance.

Review of the impact of marijuana on mental health in 2025

Marijuana, also known as cannabis, contains two main compounds that impact mental health: THC (tetrahydrocannabinol) and CBD (cannabidiol). THC is a psychoactive ingredient that can cause euphoria but also anxiety, while CBD has a relaxing effect without causing a "high." In 2025, with the increasing legalization and availability of cannabis products, scientists are actively studying how marijuana affects anxiety, depression, post-traumatic stress disorder (PTSD), and other mental health conditions. Below, I present a detailed overview, based on analysis of scientific studies from 2024 and 2025, such as those from Frontiers in Psychiatry, JAMA Psychiatry, The Lancet and others, as well as practical observations of users.

Introduction to the study

The goal was to create a unique article on the effects of marijuana on mental health, based on current research and practical tips. The analysis included studies on THC, CBD, and their effects on the endocannabinoid system, as well as the impact of dose, frequency, and individual predispositions. Sources such as Frontiers in Psychiatry, JAMA Psychiatry, The Lancet, Nature Reviews Neuroscience, Neurotherapeutics, National Institute on Drug Abuse and others, with an emphasis on data from 2024 and 2025.

The mental health benefits of marijuana

CBD for treating social anxiety

Research from 2024, published in Psychiatry Research (Therapeutic potential of cannabidiol (CBD) in anxiety disorders), conducted a systematic review and meta-analysis, including 8 articles and 316 participants. They found that CBD had a significant effect on anxiety reduction, with a Hedges' effect g = -0.92 (95% CI -1.80 to -0.04), indicating high efficacy, especially in social anxiety disorder (SAD) and generalized anxiety disorder (GAD). The study with Frontiers in Psychiatry (2024) (Cannabidiol usage, efficacy, and side effects) confirms that CBD reduces anxiety without sedative effects, making it an attractive choice for people with social anxiety.

Other studies, such as the review in Neurotherapeutics (2024) (Neurotherapeutics), indicate that CBD acts on serotonin 5-HT1A receptors, modulating the stress response, which is particularly effective in public situations such as speaking.

THC and CBD in the Treatment of PTSD

In the case of post-traumatic stress disorder (PTSD), a 2024 study published in The Lancet (The Lancet), analyzed the effectiveness of marijuana in alleviating symptoms in war veterans. In a clinical trial involving 80 participants, those receiving THC preparations (5-10 mg) combined with CBD (10-20 mg) for 12 weeks reported reduced nightmares and flashbacks compared to the placebo group. However, results were mixed – approximately 60% participants experienced improvement, but 20% experienced increased anxiety, indicating the need for an individualized approach.

Research suggests that THC may affect emotional memory, reducing the intensity of traumatic memories by activating CB1 receptors in the cerebral amygdala, which is supported by data from Frontiers in Psychiatry (2023) (Medical cannabis for treatment-resistant combat PTSD). CBD, in turn, may mitigate some of the negative effects of THC, such as anxiety and paranoia, making balanced products (e.g., 1:1 THC:CBD) potentially more suitable for PTSD patients.

Other potential benefits

Review in Nature Reviews Neuroscience (2024) (Nature Reviews Neuroscience) indicates that marijuana may support mental health by regulating the endocannabinoid system, which plays a key role in managing stress and mood. For example, CBD may increase levels of anandamide, an endogenous cannabinoid, which improves mood in people with depression, a study from JAMA Psychiatry (2025) (JAMA Psychiatry). However, these effects are often short-lived and depend on the dose and individual predisposition.

Mental health risks

Increased risk of depression

A 2025 meta-analysis published in JAMA Psychiatry (JAMA Psychiatry), analyzed data from 15 studies involving over 50,000 participants and found that heavy marijuana use (daily or almost daily) increased the risk of developing depression by approximately 17% in young adults (18-30 years old). This risk was particularly pronounced in those using high-THC products (>20%). However, in occasional users (1-2 times per week), the risk was not significantly increased, suggesting that moderation is key.

Research from the University of Bristol (2024) (2024: Cannabis – psychotic episodes) show that young people who use stronger marijuana are twice as likely to experience psychosis, which may indirectly influence the severity of depression, especially in the context of co-occurring disorders.

Risk of psychosis and schizophrenia

The relationship between marijuana and psychosis remains one of the most controversial topics. A 2024 review in Nature Reviews Neuroscience (Nature Reviews Neuroscience) confirms that individuals with a genetic predisposition to psychosis, such as a COMT gene variant, are at greater risk of developing psychotic symptoms with regular use of high-THC marijuana. The study The Lancet Psychiatry (2024) (The Lancet Psychiatry) showed that daily use of marijuana with a THC content above 10% increased the risk of a psychotic episode almost five-fold in people with a family history of schizophrenia.

PMC Research (2024) (Assessing Cannabis Use in People with Psychosis) emphasize that marijuana use is common in people with psychosis and may worsen symptoms, requiring careful clinical assessment.

Addiction and other side effects

About 9% of marijuana users develop a behavioral addiction, according to reports National Institute on Drug Abuse (NIDA). Withdrawal symptoms, such as irritability, insomnia, and loss of appetite, are usually mild and subside within 1-2 weeks. However, long-term use can lead to impaired motivation and cognitive function, especially in young people, as evidenced by data from JAMA Psychiatry (2025).

Tips for safe use

To minimize mental health risks, experts recommend the following steps:

Consultation with a doctor: People with a history of mental illness or a family history of psychosis should consult a psychiatrist before using marijuana.
Low doses: Start with small doses (e.g., 5-10 mg CBD or 2-5 mg THC) and gradually adjust as you observe your body's reactions.
Product selection: Opt for products with high CBD and low THC content to minimize psychoactive effects. Balanced products (e.g., 1:1 THC:CBD) may be safer for your mental health.
Avoiding overuse: Regular breaks (e.g., 2-4 weeks every few months) help prevent tolerance and potential addiction.
Monitoring symptoms: Pay attention to mood changes, anxiety, or difficulty concentrating and discontinue use if adverse effects occur.

Key research from 2024-2025

Test	Topic	Finds	Source
Psychiatry Research (2024)	CBD for Social Anxiety	Hedges' effect g = -0.92, highly effective in reducing anxiety.	Therapeutic potential of cannabidiol (CBD) in anxiety disorders
The Lancet (2024)	THC and CBD for PTSD	Reduction of nightmares in 60% patients, but increased anxiety in 20%.	The Lancet
JAMA Psychiatry (2025)	Marijuana and depression	Heavy use increases the risk of depression by 17% in young adults.	JAMA Psychiatry
University of Bristol (2024)	Marijuana and psychosis	Higher risk of psychosis with stronger marijuana use in adolescents.	2024: Cannabis – psychotic episodes

The impact of marijuana on mental health in 2025 is a complex issue that requires a balanced approach. Research indicates that CBD can be an effective treatment for social anxiety, offering relaxation without psychoactive effects. THC has shown potential to alleviate PTSD symptoms, but its use requires caution due to the potential for increased anxiety in some individuals. Conversely, heavy marijuana use, especially with high THC content, increases the risk of depression and psychosis, especially in those with a genetic predisposition. Responsible use is key – consulting a doctor, low doses, choosing appropriate products, and taking regular breaks can help minimize risks while maximizing potential benefits. As research in 2025 provides new data, further analysis will be crucial to fully understand the impact of marijuana on mental health.